Administration of erythropoietin to patients with heart attack who undergo coronary intervention procedures
Links shared publicly online about this topic.
- 302total visits
Administration of erythropoietin to patients with heart attack who undergo coronary intervention procedures
View full resource at sciencedaily.com
Tags: Heart, Anemia Medication, Heart Attack, Procrit, Eprex, Epogen, NeoRecormon, Epogin
Most Recently Shared on May 10, 2011 at 10:53 pm By:
ScienceDaily: Administration of erythropoietin to patients with heart attack who undergo: http://bit.ly/irzqO7 Full http://bit.ly/lsfv7k
Study examines outcomes of erythropoietin use for heart attack patients undergoing PCI
eurekalert.org — “Intravenous administration of epoetin alfa, a product that stimulates red blood cell production, to patients with heart attack who were undergoing percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries), did not provide reduction in the size of the heart muscle involved and was associated with higher rates of adverse cardiovascular events, according to a study in the May 11 issue of JAMA.” View full resource at eurekalert.org
Most Recently Shared on May 11, 2011 at 12:27 am By:
HDCN: Giving EPO to heart attack patients receiving PCI linked to increased infarct size. http://bit.ly/lu4BIU
Advertisement
